AqueSys Adds $9 Million

AqueSys Inc., a Duluth, Ga.-based developer of a device to treat primary open-angle glaucoma, has raised $9 million in Series B funding, according to a regulatory filing. Return backers include AMV Partners, Carlyle Venture Partners and SV Life Sciences. It had previously raised $6.9 million.